CD8A and neoplasm: In CD8+ T cells, METTL3 enhances the stability and translational efficiency of genes associated with the T cell receptor (TCR) signaling pathway, thereby promoting their proliferation, activation, and the expression of effector molecules, which ultimately strengthens anti-tumor immunity (106).